Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases.
about
CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent InfectionsCRISPR/Cas9, a powerful tool to target human herpesviruses.Reprogrammed CRISPR-Cas9 targeting the conserved regions of HPV6/11 E7 genes inhibits proliferation and induces apoptosis in E7-transformed keratinocytesDelayed control of herpes simplex virus infection and impaired CD4(+) T-cell migration to the skin in mouse models of DOCK8 deficiencyLytic Promoters Express Protein during Herpes Simplex Virus Latency.Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.Electric Cell-Substrate Impedance Sensing To Monitor Viral Growth and Study Cellular Responses to Infection with Alphaherpesviruses in Real Time.The Product of the Herpes Simplex Virus 2 UL16 Gene Is Critical for the Egress of Capsids from the Nuclei of Infected Cells.Systems-guided forward genetic screen reveals a critical role of the replication stress response protein ETAA1 in T cell clonal expansion.Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.The Impacts of Genome-wide Analyses on our Understanding of Human Herpesvirus Diversity and Evolution.CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses.Increasing antigen presentation on HSV-1-infected cells increases lesion size but does not alter neural infection or latency.Viral lncRNA: A regulatory molecule for controlling virus life cycle
P2860
Q28552274-18598399-D59C-41C3-8567-3243DA086B94Q34047704-E2FE73B3-F969-4176-9942-A91A4FF0762FQ35728189-D0881267-23CF-4660-A1E6-D0640B06C220Q35832670-BD77FE8A-EC1F-4E9E-A6A4-B947BAF26089Q36062519-3F8616BA-54EF-407B-94D0-A2E47217267FQ37319048-2B9DCB6A-32A8-4158-886F-AA10DB516271Q38759997-DF5E0E64-EDA4-4458-974B-48F305F87861Q38839072-00B9413B-0BDC-4A4D-8161-D7AF21F9AF7AQ38919628-62595049-8490-4DBB-9CD5-2790B7C5B302Q40162620-57349EF7-1988-4307-8E14-D4BDD3C6EBBEQ40659202-E3B5FEC6-1C2D-48D6-BC6B-F81F3DD2FFC9Q42778214-D69AD15A-D2DF-48B7-B7F9-7FD630B34A7FQ47549689-C2456224-5689-4F92-8BE2-4D797F7F4A9DQ49912490-A91CB1CD-EC43-49BB-B8B7-8D0CE73089BEQ54241403-B7DE8DFD-A285-4E65-A6D8-48A466F9BA74Q56551085-91F030B1-9EB9-4AC9-B70A-2FA0818D92ED
P2860
Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Engineering herpes simplex vir ...... ting by CRISPR/Cas9 nucleases.
@en
type
label
Engineering herpes simplex vir ...... ting by CRISPR/Cas9 nucleases.
@en
prefLabel
Engineering herpes simplex vir ...... ting by CRISPR/Cas9 nucleases.
@en
P1476
Engineering herpes simplex vir ...... eting by CRISPR/Cas9 nucleases
@en
P2093
Tijana Stefanovic
P356
10.1016/J.JVIROMET.2014.11.009
P577
2014-12-03T00:00:00Z